External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)
Clinical trial NCT05146973 · COMPLETED
Trial details
- NCT number
- NCT05146973
- Sponsor
- Telix Pharmaceuticals (Innovations) Pty Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-30
- Primary completion
- 2023-07-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.